Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2007;109:895-901
© 2007 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bracken, H.
Right arrow Articles by Winikoff, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bracken, H.
Right arrow Articles by Winikoff, B.
Related Collections
Right arrow Abortion

ORIGINAL RESEARCH

Mifepristone Followed in 24 Hours to 48 Hours by Misoprostol for Late First-Trimester Abortion

Hillary Bracken, MHS1, Nguyen Thi Nhu Ngoc, MD2, Eric Schaff, MD3, Kurus Coyaji, MD4, Shubha Ambardekar, MD4, Emily Westheimer, MSc5 and Beverly Winikoff, MD, MPH1

From 1Gynuity Health Projects, New York, New York; 2Hung Vuong Hospital, Ho Chi Minh City, Vietnam; 3Planned Parenthood of Delaware, Wilmington, Delaware; 4Department of Obstetrics & Gynecology, K.E.M. Hospital, Rasta Peth, Pune, India; and 5Brooklyn, New York.

OBJECTIVE: To investigate the efficacy of mifepristone and misoprostol for the termination of pregnancies in the late first trimester.

METHODS: This was a prospective study of 321 women seeking termination of pregnancy with gestations from 64 days to 84 days (±3 days) by vaginal ultrasonography. Women were enrolled at three sites: University of Rochester Reproductive Health Program in Rochester, New York; Hung Vuong Hospital in Ho Chi Minh City, Vietnam; and K.E.M. Hospital in Pune, India. Eligible women received 800 mcg of misoprostol vaginally between 24 hours and 48 hours after administration of 200 mg mifepristone. Two additional doses of 400 mcg of misoprostol were administered either orally or vaginally as needed every 3 hours for a maximum of two additional doses (total 1,600 mcg). The primary study outcome measure was complete abortion without surgical intervention.

RESULTS: Eighty-nine percent of women who completed the study successfully terminated their pregnancies. Most women were either satisfied (64.8%) or very satisfied (28.6%) with their experience. Ninety-four percent of women reported that they would recommend the procedure to a friend. Most women (90.4%) also agreed they would request a medical abortion if they required another abortion at this gestational age.

CONCLUSION: Medical abortion is acceptable and effective in the late first trimester and offers women an acceptable alternative to surgical abortion.

LEVEL OF EVIDENCE: II






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Obstetricians and Gynecologists.